Infasurf® (calfactant)
Prevention & Treatment of Respiratory Distress Syndrome (RDS) in newborns
ApprovedActive
Key Facts
Indication
Prevention & Treatment of Respiratory Distress Syndrome (RDS) in newborns
Phase
Approved
Status
Active
Company
About Ony Biotech
Founded in 1985 and based in Amherst, New York, ONY Biotech is a commercial-stage biotech specializing in neonatal respiratory care. Its core business is built on the FDA-approved surfactant Infasurf®, which has been a standard of care since 1998. The company is actively expanding its portfolio through clinical development of non-invasive surfactant delivery (InfasurfAero™) and partnerships for medical devices like the AerVia® Neonatal Airway, aiming to solidify its position as a leader in neonatology therapeutics and devices.
View full company profile